GlassScriptPhysician profile
Kevin P Obrien
NPI 1134131733
$12,825.52
in general payments reported to CMS, 2019-2025
34 companies · none reported in 2025
See the full distribution for Allergy & Immunology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,543 · 2020: $2,621 · 2021: $3,161 · 2022: $500.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocryst Pharmaceuticals, INC. | $7,507.35 | 2019-2020 | |
| Biocryst US Sales Co., LLC | $2,010.03 | 2021 | |
| Genzyme Corporation | $623.02 | 2019-2022 | |
| Glaxosmithkline, LLC. | $550.70 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $380.27 | 2019-2022 | |
| Grifols USA, LLC | $346.62 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $318.55 | 2019-2022 | |
| Csl Behring | $276.79 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $180.01 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $104.20 | 2019-2021 | |
| Stryker Corporation | $47.58 | 2020 | |
| Sanofi-Aventis U.S. LLC | $44.77 | 2019 | |
| Paratek Pharmaceuticals, INC. | $41.36 | 2021 | |
| Pfizer INC. | $36.89 | 2020-2021 | |
| Octapharma USA, INC. | $35.09 | 2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $31.42 | 2022 | |
| Genentech USA, INC. | $29.27 | 2019-2021 | |
| Janssen Biotech, INC. | $25.01 | 2019 | |
| Lundbeck LLC | $20.61 | 2022 | |
| Kaleo, INC. | $19.93 | 2021 | |
| Amgen INC. | $19.37 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $18.42 | 2021 | |
| Daiichi Sankyo INC. | $18.37 | 2019 | |
| Abbvie INC. | $18.20 | 2021 | |
| Circassia INC. | $17.92 | 2019 | |
| Endo Pharmaceuticals INC. | $16.58 | 2020 | |
| Incyte Corporation | $15.73 | 2022 | |
| Eyevance Pharmaceuticals LLC | $15.16 | 2021 | |
| Hikma Pharmaceuticals USA | $15.16 | 2021 | |
| Boston Scientific Corporation | $14.85 | 2022 | |
| Sanofi Pasteur INC. | $13.34 | 2019 | |
| Optinose US, INC. | $12.95 | 2019 |
2 companies reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Obrien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.